Posted: Mon Nov 20, 2006 1:50 am Post subject: Claris to become one of top three Propofol manufacturers
[size=18]Claris to become one of top three Propofol manufacturers globally - doubles manufacturing capacity[/size]
[color=darkblue]Ahmedabad, 20th November, 2006.[/color] Profol/Provive is the flagship brand of Claris, with sales in 48 countries and market leadership position in India, as well as several countries globally. In India, the brand continues to retain a market share of over 60% in the face of burgeoning competition.
The present global market for propofol is estimated to stand at over US$ 805 mn.
Profol is the advanced I.V. anesthetic propofol - the Anesthetic of choice globally due to its key benefits of faster and clear headed recovery viz-a-viz other gaseous/ I.V. Molecules that result in the after effects of nausea and vomiting, as well as longer duration of recovery. Infact the company is working on futuristic next generation molecules and delivery systems in Propofol and other emulsion areas.
Arjun Handa, Chief Operating Officer, Claris Lifesciences, said, "As part of our corporate strategy we have decided to capitalize on our manufacturing capability of emulsions and lipids which includes propofol. We have doubled our capacity as we had more than 100% capacity worth of orders from our existing presence in India and other International markets and to enhance our presence in the regulated markets “.
As a case in point, the company expects to get the product registered in over 25 European countries by mid 2007. This region itself has an estimated market size of over 55 million vials annually.
Besides the above, this is a complex technology very few companies across the world have mastered. “We also want to continue to retain our position in this technology and therefore are working on newer formulations and delivery systems”, added Arjun Handa.
“This strategy was particularly identified because it has significantly lower idea to market thruput timelines and therefore we can introduce new products faster which has helped us initiate a number of significant deals with large generic companies in the regulated markets", he confirmed.
This is another growing opportunity for Claris that can only be tapped with scale up of capacities.
Claris Lifesciences is an international pharmaceutical company, in the business of manufacturing and marketing sterile parenteral preparations, life saving medicines and hospital products, focusing on delivery systems, for treatment of critical illness and diseases.
With emphasis on Research, Technology and Quality, Claris offers a range of unique products and delivery systems in bottles, virals, ampoules, prefilled syringes, non- PVC/PVC bags and oral dosage forms. The company’s strength lies in its know- how and expertise in manufacturing and marketing injectable products.
Driven by a team of scientists, pharmaceutical experts and management professionals, Claris is powered by a combination of Vision, R&D capabilities, Technological know how, International standards and Manufacturing expertise.
The company's range of products and delivery systems extends across Enteral and Parenteral Nutrition, Anaesthesia, Blood Products and Plasma Volume Expanders, Anti-infectives, Dialysis and Transplant, Cardiac Care, Infusion Therapy as well as Medical Disposables and Equipment.
Claris enjoys Market Leadership in India. Globally, the company operates in more than 60 countries, through its subsidiaries, offices and marketing/distribution network, and a diverse customer profile covering institutions, major corporate hospitals and international aid agencies.
[color=darkblue]For more information:.[/color]
Shekhar Singh /Sachin Jain.
Mutual Public Relations
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum